Industry: Pharmaceuticals, Biotechnology
Emergent Genetics (EG) is a private equity investment firm focusing exclusively on seed and related biotechnology. The principals of EG, together with its management team, have extensive experience in seed operations and biotechnology industry relationships. This experience stems from longstanding involvement in technology development and cross licensing relations with multinational trait providers as well as many years of experience developing and operating over a dozen agricultural biotechnology ventures. The Company was founded in 1998 in affiliation with Hicks Muse Tate & Furst. EG’s current portfolio includes investments in the United States, India, South America and Europe. ( www.emergentgenetics.com )
Emergent Genetics Inc.
6625 Lenox Park Drive Ste. 117
Memphis, Tennessee 38115
USA
Tel: (901) 375-5806
Fax: (901) 375-5860